| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Codexis, Inc.'s insiders have reduced their positions by a net 12,670 shares worth roughly $17K. In the past 30 days, 0 insiders bought and 2 sold.
On the other side, 2 insiders reduced their position over the period. CDXS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 244.2K | $332.2K | -6,335 | |
| 10% | 180.0K | $300.1K | - | |
| ? | 139.0K | $217.1K | - | |
| Other | 138.8K | $235.5K | - | |
| Dir | 66.3K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 25,000 | $2.91 | $72,720.00 | +0.3% | +71.1% | -7.4% | |
| Sep 25, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 85,000 | $2.93 | $249,146.50 | +1.0% | +71.8% | -17.5% | |
| Sep 23, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 1,100,000 | $3.01 | $3,308,034.50 | +15.0% | +68.8% | -15.8% | |
| Sep 18, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 61,000 | $3.16 | $192,991.80 | +42.4% | +81.0% | -19.9% | |
| Nov 15, 2023 | Dorgan Byron L | - | Sell | 20,000 | $2.11 | $42,168.00 | -9.4% | +29.9% | +78.9% | |
| Sep 11, 2023 | Norrett Kevin71 | Chief Operating Officer | Buy | 9,000 | $1.72 | $15,479.10 | +10.1% | +18.7% | +52.8% | |
| Sep 8, 2023 | Fitzgerald Margaret Nell72 | See Remarks | Buy | 11,834 | $1.70 | $20,064.55 | +17.0% | +27.9% | +59.3% | |
| Sep 8, 2023 | Dilly Stephen George72 | See Remarks | Buy | 58,479 | $1.73 | $100,952.30 | +15.4% | +27.9% | +59.3% | |
| Sep 8, 2023 | Ryali Sriram | Chief Financial Officer | Buy | 11,650 | $1.70 | $19,856.26 | +10.4% | +27.9% | +59.3% | |
| Apr 18, 2023 | Nicols John J86 | Director | Sale+OE | 71,428 | $4.19 | $299,251.18 | -8.4% | -22.8% | -33.7% |